KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
$2.46
+0.160 (+6.96%)
At Close: Apr 26, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile
Date Action Amount Person Type
Apr 17, 2024 Buy 29 800 Reznick Yehuda Common Stock
Apr 01, 2024 Buy 0 Reznick Yehuda
Jan 30, 2024 Buy 3 750 Aghion Daniel Common Stock
Jan 04, 2024 Buy 295 500 Kidron Miriam Common Stock
Jan 04, 2024 Buy 329 000 Kidron Nadav Common Stock
Jan 04, 2024 Buy 180 500 Hexter Joshua Common Stock
Jan 04, 2024 Buy 136 500 Silberman David Common Stock
Jan 04, 2024 Buy 9 325 Sank Leonard Common Stock
Jan 04, 2024 Buy 30 000 Sank Leonard Common Stock
Jan 04, 2024 Buy 8 820 Rozov Yadin Common Stock
Jan 04, 2024 Buy 30 000 Rozov Yadin Common Stock
Jan 04, 2024 Buy 9 325 Mayer Arie Common Stock
Jan 04, 2024 Buy 30 000 Mayer Arie Common Stock
Jan 04, 2024 Buy 5 070 Aghion Daniel Common Stock
Jan 04, 2024 Buy 30 000 Aghion Daniel Common Stock
Jan 04, 2024 Buy 5 070 Shapiro Benjamin Common Stock
Jan 04, 2024 Buy 30 000 Shapiro Benjamin Common Stock
Jan 01, 2024 Buy 0 Aghion Daniel
May 26, 2023 Buy 120 000 Kidron Nadav Common Stock
May 26, 2023 Buy 53 500 Kidron Miriam Common Stock
May 26, 2023 Buy 20 500 Derovan Netanel Common Stock
May 26, 2023 Buy 27 000 Hexter Joshua Common Stock
May 26, 2023 Buy 24 500 Silberman David Common Stock
May 01, 2023 Buy 20 000 Shapiro Benjamin Common Stock
May 01, 2023 Buy 0 Shapiro Benjamin Common Stock
Apr 17, 2023 Buy 30 000 Sank Leonard Common Stock
Apr 17, 2023 Buy 81 000 Derovan Netanel Common Stock
Apr 17, 2023 Buy 108 000 Hexter Joshua Common Stock
Apr 17, 2023 Buy 279 000 Kidron Nadav Common Stock
Apr 17, 2023 Buy 30 000 Rozov Yadin Common Stock
Apr 17, 2023 Buy 213 000 Kidron Miriam Common Stock
Apr 17, 2023 Buy 97 500 Silberman David Common Stock
Apr 17, 2023 Buy 30 000 Mayer Arie Common Stock
Apr 04, 2023 Buy 3 800 Mayer Arie Common Stock
Apr 03, 2023 Buy 5 009 Mayer Arie Common Stock
Mar 16, 2023 Buy 26 000 Kidron Nadav Common Stock
Mar 14, 2023 Buy 100 000 Kidron Nadav Common Stock
Mar 14, 2023 Sell 100 000 Kidron Miriam Common Stock
Mar 14, 2023 Buy 50 000 Rozov Yadin Common Stock
Mar 13, 2023 Buy 20 000 Rozov Yadin Common Stock
Jan 03, 2023 Sell 1 425 Rabinowitz Michael Common Stock
Jan 03, 2023 Sell 11 900 Rabinowitz Michael Common Stock
Oct 27, 2022 Sell 25 000 Kidron Nadav Common Stock
Aug 08, 2022 Buy 20 000 Sank Leonard Common Stock
Aug 08, 2022 Sell 9 304 Sank Leonard Common Stock
Aug 08, 2022 Sell 20 000 Sank Leonard Stock Option
Jul 28, 2022 Buy 12 000 Rozov Yadin Common Stock
Jul 28, 2022 Buy 12 000 Mayer Arie Common Stock
Jul 28, 2022 Buy 30 000 Derovan Netanel Common Stock
Jul 28, 2022 Buy 84 000 Kidron Miriam Common Stock
Jul 28, 2022 Buy 126 000 Kidron Nadav Common Stock
Jul 28, 2022 Sell 12 631 Kidron Nadav Common Stock
Jul 28, 2022 Buy 34 000 Kidron Nadav Common Stock
Jul 28, 2022 Buy 42 000 Hexter Joshua Common Stock
Jul 28, 2022 Buy 12 000 Sank Leonard Common Stock
Jul 28, 2022 Buy 39 000 Silberman David Common Stock
Jul 28, 2022 Buy 30 000 Rabinowitz Michael Common Stock
May 02, 2022 Buy 7 500 Rozov Yadin Stock Option (right to buy)
Apr 01, 2022 Buy 0 Rozov Yadin
Mar 21, 2022 Sell 10 000 Rakin Kevin Common Stock
Feb 17, 2022 Buy 6 667 Rakin Kevin Common Stock
Feb 17, 2022 Sell 3 010 Rakin Kevin Common Stock
Feb 17, 2022 Sell 6 667 Rakin Kevin Stock Option (right to buy)
Feb 11, 2022 Sell 5 000 Rakin Kevin Common Stock
Feb 11, 2022 Sell 5 000 Rakin Kevin Common Stock
Jan 09, 2022 Buy 30 000 Derovan Netanel Stock Option (right to buy)
Jan 09, 2022 Buy 18 000 Derovan Netanel Common Stock
Jan 09, 2022 Buy 0 Derovan Netanel
Jan 03, 2022 Buy 6 000 Mayer Arie Common Stock
Jan 03, 2022 Buy 63 000 Kidron Nadav Common Stock
Jan 03, 2022 Buy 150 000 Kidron Nadav Common Stock
Jan 03, 2022 Sell 48 752 Kidron Nadav Common Stock
Jan 03, 2022 Buy 107 000 Kidron Nadav Stock Option (right to buy
Jan 03, 2022 Buy 10 000 Sank Leonard Stock Option (right to buy)
Jan 03, 2022 Buy 6 000 Sank Leonard Common Stock
Jan 03, 2022 Buy 10 000 Mayer Arie Stock Option (right to buy)
Jan 03, 2022 Buy 6 000 Mayer Arie Common Stock
Jan 03, 2022 Buy 63 000 Kidron Nadav Common Stock
Jan 03, 2022 Buy 150 000 Kidron Nadav Common Stock
Jan 03, 2022 Sell 48 752 Kidron Nadav Common Stock
Jan 03, 2022 Buy 107 000 Kidron Nadav Stock Option (right to buy
Jan 03, 2022 Buy 42 000 Kidron Miriam Common Stock
Jan 03, 2022 Buy 72 000 Kidron Miriam Stock Option (right to buy)
Jan 03, 2022 Buy 19 000 Rabinowitz Michael Common Stock
Jan 03, 2022 Buy 32 000 Rabinowitz Michael Stock Option (right to buy)
Jan 03, 2022 Buy 6 000 Rakin Kevin Common Stock
Jan 03, 2022 Buy 10 000 Rakin Kevin Stock Option (right to buy)
Jan 03, 2022 Buy 21 000 Hexter Joshua Common Stock
Jan 03, 2022 Buy 36 000 Hexter Joshua Stock Option (right to buy)
Jan 03, 2022 Buy 19 000 Silberman David Common Stock
Jan 03, 2022 Buy 32 000 Silberman David Stock Option (right to buy)
Jan 03, 2022 Buy 10 000 Friedman Aviad Stock Option (right to buy
Jan 03, 2022 Buy 6 000 Friedman Aviad Common Stock
Jan 03, 2022 Sell 6 000 Friedman Aviad Common Stock
Jan 03, 2022 Sell 10 000 Friedman Aviad Stock Option (right to buy
Dec 30, 2021 Sell 20 000 Kidron Nadav Common Stock
Dec 28, 2021 Sell 31 728 Kidron Nadav Common Stock
Dec 28, 2021 Sell 9 532 Rabinowitz Michael Common Stock
Dec 16, 2021 Sell 5 000 Rakin Kevin Common Stock
Nov 01, 2021 Sell 3 000 Mayer Arie Common Stock
JSON CSV
INSIDER POWER
91.520
Last 100 transactions
Buy: 3 987 636 | Sell: 392 701 (Shares)

Based on the 100 latest insides trades, we have calculated the insider power to be positive at a ratio of 91.520.

In total, the insiders bought 3 987 636 and sold 392 701 ORMP shares in the last 100 trades.

Click to get the best stock tips daily for free!

About Oramed Pharmaceuticals Inc.

Oramed Pharmaceuticals. Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for the treatment of individuals with diabetes. It is also developing ORMD-0901, an oral glucagon-like peptid... ORMP Profile

Golden Star

Ticker Date Change Price
DHT Apr 24 2.04% $11.28
MLI Apr 19 9.66% $52.28
LPLA Apr 19 1.42% $262.59
DOOR Apr 18 0.167% $131.39
LNG Apr 17 1.49% $156.81
FCN Apr 16 1.80% $207.62
ELV Apr 16 5.97% $506.97
AKR Apr 05 4.78% $16.53
ITCI Apr 05 7.04% $68.44
VSTS Apr 04 0.425% $18.82
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT